| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 | Texcell Expert in viral safety since 1987. Texcell is a dedicated partner for biotechnology and pharmaceutical companies since more than 2 decades. Thanks to an unique combination of expertise in Virology and Immunology, we can provide a full support to your product development from the proof of concept to clinical studies and GMP manufacturing. Our state-of the Art facilities are located in France, Germany and in the US where we use most recent technologies to efficiently perform a wide range of assays What do we provide ? A specialized analytical lab for your preclinical and clinical studies, including: - Cell based … Type: | 7 | 0 | 7 | 113 |
 |  PureTech Health Giving Life to Science PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 29 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed … Type: | 11 | 0 | 5 | 117 |
 | PharmEnable Therapeutics Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innovative small molecule drugs PharmEnable is a biopharmaceutical company utilizing AI to discover effective small-molecule medicines for disease targets that are inaccessible to antibodies. With our proprietary AI-enabled drug discovery platform, chemSEEK, we explore new chemical spaces and discover novel small molecules with antibody-like specificity and selectivity. We are developing a pipeline of wholly owned therapeutics with initial focus on oncology and neurology. We also engage in drug discovery partnerships across a range of disease areas where accessing the target poses a significant challenge. PharmEnable is based in Cambridge, … Type: | 3 | 1 | 1 | 23 |
 | Hulptroepen Alliantie [Automatic translation follows] Auxiliary Alliance supplies personal protective equipment, rapid tests and antibody tests to healthcare organizations, companies and consumers. Type: | 1 | 1 | 0 | 3 |
 | Röchling Medical Medical plastics solutions for every patient, everywhere, every day We are a preferred supplier and development partner of leading pharmaceutical, biotech and medical technology companies worldwide. Under cleanroom conditions, we manufacture customized pharmaceutical packaging and delivery solutions, consumables for diagnostics, and sophisticated components and assemblies for medical devices. Our customers are pioneers in disease prevention and health restoration. As a reliable partner for integrated solutions, we help to keep it that way. At our sites around the world, we jointly develop innovative and customized plastic products, services, and platform solutions. As a family-owned company, we enable our customers worldwide to … Type: | 0 | 0 | 0 | 269 |
 | Anavex Life Sciences Anavex utilizes genomic biomarkers in precision medicine to treat severe neurological disorders Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, including Alzheimer's disease, Parkinson's disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, pain, and various types of cancer. Anavex's lead drug candidate, ANAVEX®2-73 (blarcamesine), has successfully completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease, a Phase 2 proof-of-concept study in Parkinson's disease dementia, and both a Phase 2 and a Phase 3 study … Type: | 1 | 0 | 1 | 49 |
 | Cernostics Providing Deeper Tissue Insights Cernostics has joined Castle Biosciences. Please stay connected! https://www.linkedin.com/company/castle-biosciences-inc-/ Cernostics is a diagnostics company focused on delivering next generation cancer diagnostics and prognostics through a unique approach to tissue analysis. Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple interacting cell types. Cernostics takes a tissue systems biology approach to anatomic pathology. Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics. Learn more about our technology platform … Type: | 0 | 0 | 0 | 510 |
 | Rahko Part of Odyssey Therapeutics Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine. Read more: https://odysseytx.com/news/ Type: | 4 | 0 | 2 | 1 |
 |  Milestone Pharmaceuticals, Inc. Headquartered in Montreal, with a growing subsidiary in Charlotte, NC Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a novel, potent and short-acting calcium channel blocker designed by … Type: | 0 | 0 | 0 | 52 |
 | Sirona Biochem Corp. Advancing chemistry. Enhancing health. Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential. Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem (located in France) is the recipient of multiple French scientific awards and European Union and French government grants. Sirona Biochem is a publicly-traded company. The company is listed on the TSX Venture Exchange in Canada … Type: | 4 | 0 | 3 | 6 |
 | Association Ville Hôpital Lutter contre la Douleur [Automatic translation follows] Contribute to improving the pathways of complex chronic pain patients Our objective is to intervene in support of primary care healthcare professionals caring for chronic pain patients in complex situations in the Ile de France region. The system offers information and training to healthcare professionals to harmonize practices and thus enable the decompartmentalization, coordination and continuity of care provided to chronic pain patients in complex situations. This network organization aims to improve the quality of care for patients suffering from chronic pain whatever its origin: pain resulting from cancer, headaches, chronic lower back pain, migraines, neuropathic pain, … Type: | 2 | 0 | 2 | 4 |
 | Axoltis Pharma The CNS Regeneration Company Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders. neurodegenerative diseases, neurodegeneration, spinal cord injury, peptide, neuroprotection, neural repair, regeneration, drug, biotechnology, pharma, CNS, neurology, ALS, Parkinson, and Multiple Sclerosis Type: | 3 | 2 | 1 | 12 |
 | Cellvax Cellvax, founded in 2001, is a preclinical biotech company which provides in vitro and in vivo studies allowing accelera Cellvax, founded in 2001, is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases, mainly in Cancer and Osteoarthritis (OA) fields. Cellvax is a fast-growing technology-driven preclinical service company. Today, Cellvax directly employs and through R&D collaborations motivated and differently skilled scientists and engineers, working in interdisciplinary teams on several innovative products. Preclinical studies CRO, Animal models, Cancer, Osteoarthritis, Bio-markers, … Type: | 0 | 0 | 0 | 8 |
 | CHELATEC Reliable partner for reliable molecules Chelatec is a client oriented Contract Research Organization (CRO) specializing in radioactive labelling and preclinical investigations. Our mission is to assist the pharmaceutical and biotechnology industry along the drug development process by using the radioactive tracer in non-clinical studies (ADME/PK) and bioanalyses (immunoassays). Our services include: - Custom Radiolabelling (3H, 67Ga, 90Y, 111In, 123I, 125I, 131I, 177Lu...) - In vitro assays - In vivo ADME/PK - Radiopharmaceuticals services Radiolabeling, In vitro bioanalyses, in vivo ADME/PK, and R&D support in Radiopharmaceuticals Type: | 1 | 1 | 0 | 14 |
 | Eurofins Spincontrol The expert of efficacy testing:from consumer tests to innovative and tailor-made clinical protocols 🔎 Spincontrol is specialized in the scientific substantiation of aesthetical and well-being claims for cosmetics, food supplements, medical devices and borderline products. 💡 Recognized as one of the most innovative laboratories, our know-how and creativity are dedicated to the accuracy of your clinical trials. 👨💻 More than a response to regulation, our tests are genuine promotional support of your products. ✨ Our philosophy is to provide technological knowledge and know-how to our customers with honesty, transparency and ethics, under a recognized quality standard system, ISO 9001. 🌍 … Type: | 4 | 1 | 3 | 30 |
 | NEUROFIT Providing efficient preclinical research models for central nervous system and peripheral nervous system disorders. NEUROFIT, founded in 1996, is a pre-clinical CRO (Contract Research Organization) based in France and offering a comprehensive list of disease models and screening assays in the fields of psychiatry, neurology, multiple sclerosis, diabetes and pain. Neurofit works for major pharmaceutical and Biotech companies in Europe and the USA. Neurofit’s core expertise in CNS and PNS includes animal behavior techniques, nerve conduction velocity measure, nerve fiber morphometry, primary neuronal cell cultures. Neurofit has long-standing experiences in psychiatric, neurodegenerative and autoimmune / inflammatory disorders. Our disease models … Type: | 4 | 0 | 1 | 20 |
 | CLINACT Contract Research Organisation CLINACT, a MultiHealth Group company, is a Contract Research Organisation (CRO) assisting you in your health products development: pharmaceutical, medical devices, biotechnology, cosmetics, nutrition... With more than 20 years of experience, CLINACT provides its expertise for large range of innovative services: - Clinical operations - Biometrics - Medical and regulatory affairs - Pharmacovigilance, medical device vigilance and other vigilances - E-tools : Clinfile - Outsourcing and recruting : TempoPHARMA - Professional Training : FORMATIS This range of services fully covers industrials or academic organisations' requirements. As a MultiHealth company, CLINACT can also provide specific services withtout any … Type: | 5 | 0 | 5 | 118 |
 | Agro-Bio Antibodies Our specificity, your antibodies Pioneer in antibodies’ field, Agro-Bio provides you its expertise and its know-how for production, development and characterization of antibodies. For over 40 years, our team supports pharmaceutical and in vitro diagnostic industries as well as public institutions for their immunology issues. We collaborate both to offer you the most suitable and effective solution. Our goal is the success of your projects. Our services around antibody: • Bioanalysis/Biopharma: o Anti-idiotypic antibodies for positive control, PK and potency test, o Host Cell Protein issue management: specific anti-HCP antibodies, 2D Western Blot coverage analysis, specific ELISA kit, o Epitope … Type: | 0 | 0 | 0 | 48 |
 | Oroxcell Highlight Innovation Oroxcell is an independent research organization (CRO) offering research services assessing the safety, toxicity and efficacy of active ingredients and finished formulations. Specialized in in-vitro testing, particularly in 3D Human Models, Oroxcell is developing its business on two fronts: • Safety & efficacy testing: From screening to GLP Compliant studies, we provide well established In-vitro platform, 2D and 3D models, for performing routine and regulatory safety testing, ADME (Absorption, Distribution, Metabolism, and Elimination) and Toxicity (sensitization, phototoxicity and genotoxicity) tests, bioanalytical studies, for evaluating pharmaceuticals, medical devices, cosmetics, nutraceuticals, home care and chemical products. • Research & Innovation: … Type: | 2 | 0 | 0 | 16 |
 | GENEPEP - PEPTIDE Peptide Chemistry company for design, synthesis, stability studies and chemical optimisation (SAR studies)- CIR agrement PEPTIDES, PEPTIDE LIBRARIES AND PROTEINS Innovative chemistry for therapeutic, diagnostic and cosmetic applications GENEPEP is a CRO company (with CIR agreement) focused on peptide synthesis & services : - Tools for nanoparticles & surface functionalization - Custom synthesis of peptides, proteins & peptide libraries - Catalog of toxins, peptides & pseudopeptides - Design & synthesis for SAR studies (optimisation of solubility, stability, efficacy,...) - Stability & solubility tests - Partner of European programs, ANR, FUI etc... Type: | 1 | 0 | 1 | 13 |
 | BIO-HC The cosmetic expertise from the ingredient to the finished product Specialized in the assessment of finished cosmetic products, ingredients and cosmetic raw materials, we perform tolerance and efficacy studies. BIO-HC in-vitro : toxicological and pharmacological tests on cell models (primary cells, cell lines) and tissue models (epidermis, skin reconstructed in vitro). In vitro tests, GLP studies, and OECD tests Type: | 1 | 0 | 1 | 2 |
 | ERMO ERMO est un expert reconnu dans la conception et la fabrication de moules d'injection de haute précision. ERMO is a well-known specialist in the design and manufacture of high precision injection moulds for the plastics industry covering a wide range of technical applications and business sectors. The French-based business unit is a leading player in the manufacturing of high-tech multicavity tools for beauty & healthcare, beverage & home, medical and thin wall packaging fields. With close to 40 years of operations, ERMO is the perfect partner in the plastic injection tooling industry. Contact us for further information. injection mold, packaging, … Type: | 4 | 0 | 4 | 12 |
 | GALENIX INNOVATIONS Galenix, a Key pharmaceutical R&D partner, helps you to reduce your timeline by offering innovative solutions DRUG DELIVERY SOLUTIONS - DRUG PRODUCT DEVELOPMENT - LICENSING-OUT OPPORTUNITIES Galenix provides a range of full R&D pharmaceutical services and Drug Delivery Solutions to health companies for fast access of their products on the market. ●●● From the sourcing of the API through the Drug Product development process, including preformulation, formulation, to clinical supplies, quality control, ICH stabilities and regulatory dossier submission for Europe and US FDA registration. Galenix provides its customers drug products “ready to launch” holding a Marketing Authorization. ●●● Galenix Innovations … Type: | 0 | 0 | 0 | 12 |
 | ICARE* Icare : Expert dans la maîtrise de la sécurité des produits de santé Groupe ICARE : Votre partenaire expert de la sécurité des produits de santé Avec 30 ans d’expérience, le Groupe ICARE se distingue comme un leader en matière de normalisation et de réglementation internationale. Nous guidons les acteurs du secteur de la santé à travers le complexe paysage réglementaire, assurant que chaque dispositif et produit de santé est commercialisé en toute conformité et sécurité. Notre expertise couvre un large éventail de services essentiels pour garantir l’excellence et la conformité de vos produits : • Biocompatibilité et Toxicologie : … Type: | 16 | 4 | 15 | 201 |
 | RCTs Partenaire de l’innovation médicale RCTs is a French and International Full-Service CRO with more than 30 years of experience and over 700 projects conducted: clinical studies from phase I to phase IV, real-life or public health impact studies, medical and administrative assessments of SNDS (National Health Data System) databases, in various therapeutic areas (oncology, diabetes, cardiology, rheumatology, infectious diseases, central nervous system, vaccines...), for drug and medical device manufacturers, as well as for academic sponsors, institutions, learned societies and patient associations. Besides, RCTs has an expertise in clinical evaluations (CEP and CER) and regulatory consulting for medical devices. It is … Type: | 5 | 0 | 5 | 44 |
 | BIOSYNEX Diagnostics Innovation for Biotherapies BIOSYNEX was founded in 2005 and is one of the most significant European manufacturers and provider of rapid membrane tests in the in-vitro diagnostic market. By staying close to our customers and business partners we are aware of the needs and expectations they may have of our products and services. Listening to their voice, together with the help of our Research and Development laboratories in France and our state of the art manufacturing facilities, allows us to identify new applications in rapid testing, develop and launch innovative products and provide high quality services. Our aim is to … Type: | 1 | 0 | 1 | 59 |
 | Roowin Small molecule GLP/GMP manufaturing Roowin is a privately owned Contract Research Organisation (CRO) headquartered at Riom, Auvergne, France. Its core business being in high value added fine chemistry, Roowin offers services in the following areas: • GMP synthesis • Clean room synthesis • Lead optimization • Scale up, process development • Custom synthesis • Analytical chemistry services We are proud to be able to accompany our customers from early drug discovery over process development to medium-scale GMP production, supporting our operations by strong analytical chemistry capabilities. GMP production, Lead Optimization, Clean room synthesis, Custom Synthesis, scale up, and process development Type: | 0 | 0 | 0 | 26 |
 | Voisin Consulting Life Sciences (VCLS) Global reference partner to expedite access of HealthTech products to regulated markets. From discovery to product launch and lifecycle management At VCLS (Voisin Consulting Life Sciences), regulatory science guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. Starting early in the process, from discovery to the patient, VCLS assists innovators in designing optimized product development plans and regulatory strategies, combining the health ecosystem with commercial success. With a presence in seven locations across three continents and over 200 employees, VCLS serves a broad range of healthtech developers and their investors. Together, we accompany global stakeholders to expedite HealthTech … Type: | 7 | 1 | 5 | 235 |
 | LFB Biomanufacturing Your CDMO partner for antibodies and recombinant proteins LFB Biomanufacturing is an expert CDMO in the development and manufacture of recombinant proteins via cell culture, with specific know-how in the area of monoclonal antibodies (mAbs). LFB Biomanufacturing supplies a full range of bioproduction services, from the development of cell lines to the manufacturing clinical and commercial batches of active substances from biological products up to multiple pool of 2000L Cell Culture production capacities using Disposable Bioreactors Technology and exclusively Single-Use systems. The Alès site is regulary inspected by Customers as well as Health Agencies, including French-ANSM and US-FDA. LFB Biomanufacturing … Type: | 5 | 0 | 3 | 131 |
 | COVALAB Covalab is a French biotechnology company specialized in antibody engineering, founded in 1995. We are expert in the design and development of antibody (polyclonal, monoclonal scFv, FAb, VHH, recombinant antibodies) using antigen or DNA immunization. In addition, we offer purified and labeling antibodies, peptide synthesis for research use, diagnostic and therapeuthic. As a producer, we supply many distributors to sale our innovative and high quality antibodies. Wide range of those products are available in our website. The service activity of CovalAb represents the top of the scientific and technical iceberg which the team at CovalAb has put together. Indeed, the … Type: | 5 | 2 | 3 | 23 |
 | UNION PLASTIC Global Expert, from Design to Manufacturing, of Innovative Healthcare Industry-Specific Plastic solutions. Global Expert, from the design to the manufacturing, of Innovative Healthcare Industry-specific Plastic solutions. An extensive range of certified high-quality products for all your projects: - Dosing Systems and Administration Systems of Heathcare Products - Pharmaceutical Primary Packaging - Components devices and Medical devices - Diagnosis Consumables www.union-plastic.com Expert mondialement reconnu du design à la fabrication de solutions plastiques innovantes dédiées aux industries de la santé. Une gamme complète de produits certifiés de haute qualité pour vos projets : - Systèmes de dosage et d'administration de produits de … Type: | 2 | 0 | 2 | 124 |
 | RD-BIOTECH Biomanufacturing, development & analytical services: Plasmids, Antibodies, Recombinant proteins, Cells - FastELISA kits French CRO Biotechnology 🔎 BIOMANUFACTURING: Plasmids (R&D and High Quality grades, And Now a pDNA GMP unit), Monoclonal antibodies, Recombinant antibodies (scFV, Fab, bispecific...), recombinant proteins (E.Coli, Cell free system, Yeast and mammalian cells), cells. 💡 Antibody engineering & molecular biology platforms: Antibody sequencing, vector design & cloning, Recombinant antibody production, Chimerization and Humanization, cell line development... ✍ Analytical services: immunoassays development, antibody characterisation, quality controls (R&D and high quality grades) FastELISA kits: Immunoglobulin quantification (human, mouse, rat, bovine), Mouse Immunoglobulin isotyping, Contaminant detection (Protein A), other … Type: | 8 | 2 | 0 | 50 |
 | PHYLOGENE Time to think out of the box Founded 1999, PHYLOGENE is a CRO in genomics, transcriptomics (Rt-PCR, MLST, CRISPR), proteomics (immunotechniques and LCMS) metabolomics (LCMS) with bioinformatics support Main activities are biomarker research and validation. Methods perfecting, development and validation: ELISA, PCR, RtPCR, High Resolution LC-MS/MS for Label-Free and MRM methods. PHYLOGENE main customers are pharmas, biopharmas, cosmetics, biotechs and food companies omics Type: | 2 | 1 | 1 | 8 |
 | ILSA Manufacturer of Laboratory Instruments and Automated Systems iLsa is a key player in the field of laboratory instrumentation for in-vitro diagnostics with 40 years of experience and 10,000 instruments installed world-wide. 2 industrial sites : Besançon (France) : R&D and instruments manufacturing. Saint Ouen l’Aumône (France) : R&D and plastic consumables manufacturing in automated clean room. ILSA activity is based on two departments : iLsa Manufacturing designs and manufactures instruments and plastic consumables for In Vitro Diagnostic companies. iLsa Diagnostic is present on the international market - For Blood Transfusion Centers and Bio-Banks, iLsa Diagnostic is the market leader in … Type: | 1 | 1 | 0 | 24 |
 | Sleepinnov Technology Sleepinnov Technology is a Medical Device company located in 340 rue de l'eygala, Moirans, RA, France. Type: | 0 | 0 | 0 | 10 |
 | CEHTRA Your Specialties, Our Expertise CEHTRA stands for Consultancy for Environmental & Human Toxicology and Risk Assessment CEHTRA is an international leader in technical and regulatory support with regard to the safety of chemical products. Our focus is on scientific and innovative solutions ensuring regulatory compliance of chemicals to international obligations: from portfolio strategy to notification of chemicals and from human exposure to site audits. CEHTRA consultants provide high quality regulatory services to companies such as yours committed to the safety of their products at optimized costs. CEHTRA differentiates itself by responding to the strategic challenges of its clients by: A … Type: | 5 | 4 | 3 | 90 |
 | QIMA Life Sciences Your Partner in Innovation QIMA Life Sciences (formerly Bioalternatives, Synelvia, Newtone Technologies and Monasterium Laboratory) is a Contract Research Organization (CRO) specializing in cellular and molecular pharmacology. We offer assays ranging from in silico screening to non-invasive clinical sample bioanalysis, as well as in vitro and ex vivo assays. QIMA Life Sciences contributes to the development of in vitro methods, by offering solutions dedicated to preclinical research and to the development of drug candidates and to cosmetic active ingredients and formulations. QIMA Life Sciences can assist the health industry with its new strategic choices and helps the marketing and R&D … Type: | 4 | 0 | 5 | 58 |
 | BIOTRONIK France [Automatic translation follows] Excellence for Life BIOTRONIK is a global medical device company providing products and services for the treatment of cardiovascular and endovascular diseases. Patient well-being is our main priority. For 60 years, we have been driven by the desire to save lives and improve the quality of life of patients. With thousands of employees in more than 100 countries, we are among the world's leading medical technology innovators in the areas of cardiac rhythm management, electrophysiology and vascular intervention. Our technology empowers doctors around the world to provide their patients with the best possible healthcare. Heart rate management … Type: | 0 | 0 | 0 | 48 |
 | Banook Group People serving Science, Science serving people Since 1999, Banook Group is one of the few established international providers of cardiac safety services, central imaging, endpoint adjudication, eCOA/ePRO and Virtual Clinical Trials. From early to late stage, generation and management, provisioning to scientific analysis, Banook Group and its medical expertise has become a key player for clinical trials. To learn more, please visit our website www.banookgroup.com Cardiac Safety, Endpoint Adjudication, Central Imaging, eCOA/ePRO, Virtual Clinical Trials, Clinical Project Management, Clinical Trial Provisioning, and Clinical Trial Support Type: | 3 | 1 | 2 | 44 |
 | MAPAR Mises Au Point Anesthésie-Réanimation [Automatic translation follows] Association located at the DAR of Bicêtre hospital, organizer of the eponymous congress, seminars and EPU MAPAR was created in 1982 by the Department of Anesthesia-Intensive Care at Bicêtre hospital. The Annual Congress has quickly become one of the major national conferences in the specialty. This congress is based on an educational philosophy, a state of mind which aims to favor the communication of information useful to the clinician and to strengthen their decision-making capacity by informing clinical practice thanks to theoretical supports. MAPAR also organizes courses in the snow, at the sea and... at the hospital. … Type: | 1 | 0 | 0 | 4 |
 | ETAP-Lab - Preclinical CRO 30 years of expertise in preclinical pharmacology ETAP-Lab provides preclinical models and services in the fields of Dermatology, Stroke and Neurodegenerative Diseases. The company has strong expertise in the field of Dermatology research and offers a large portfolio of original in vivo rodent models such as chronic skin inflammation, ischemic ulceration, psoriasis, hyperkeratosis, wound healing, atopic dermatitis, actinic keratosis, skin cancer... ETAP-Lab is also leader in the field of preclinical stroke research with a unique model portfolio consisting of innovative and translational models proposed under the brand Strok@lliance. With more than 2 decades of experience, ETAP-Lab has become a best-in-class … Type: | 6 | 1 | 0 | 29 |
 | BioCytex BioCytex is a contract research organization specializing in biomarker detection and analysis of normal and pathological cells in whole blood, bone marrow and other tissue samples. With over 20 years of experience in flow cytometry, we have a wide range of experience in developing and validating assays to suit many different requirements including immunophenotyping, detection of intracellular / extracellular markers, antigen binding assays. With the capacity to simultaneously measure multiple parameters on hundreds of individual cells per second, flow cytometry is a powerful technology with a wide variety of applications in pharmaceutical development. BioCytex is working with worldwide pharmaceutical companies. … Type: | 0 | 0 | 0 | 23 |
 | ANGANY Immunity Humanité ANGANY is an emerging, private pharmaceutical company, based in Quebec City, Canada. ANGANY has tackled the specific challenges of allergy to invent first-in class pharmaceuticals. ANGANY has developed an exclusive vaccine platform based on synthetic biology: the eBioparticle TM self-adjuvant vector. ANGANY also produces high quality, high purity allergens for diagnostic purposes. Finally, ANGANY has developed a flexible, fast and highly scalable 3rd generation plant production platform. ANGANY's vaccine approach opens the door to applications in cancer, infectious, autoimmune diseases and others. ANGANY is a Franco-Canadian collaboration led by Louis-Philippe Vézina, a renowned pharmaceutical entrepreneur. allergenes recombinants, immunotherapy, … Type: | 0 | 0 | 0 | 20 |
 | APTEEUS Reconcile the time of Research with the one of Medecine APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured. Type: | 0 | 0 | 0 | 9 |
 | First Wave BioPharma, Inc. Targeted, Non-Systemic Therapies for Gastrointestinal Diseases First Wave BioPharma, Inc. (formerly AzurRx BioPharma) is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. First Wave is currently advancing a therapeutic development pipeline populated with multiple clinical stage programs built around its two proprietary technologies – niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. First Wave’s niclosamide portfolio is led by three clinical programs: FW-COV, for COVID-19 gastrointestinal infections; FW-UP, for ulcerative proctitis … Type: | 1 | 0 | 1 | 14 |
 | Neurolixis New treatments for central nervous system disorders Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain. Neuroscience, Drug development, Rett Syndrome, Parkinson's disease, Biased agonism, and Orphan Drug Type: | 2 | 1 | 1 | 7 |
 | Adverum Biotechnologies We are on a global mission to establish gene therapy as a new standard of care for the leading causes of vision loss. Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases with the aspiration of developing functional cures to restore vision and prevent blindness. Leveraging the research capabilities of its proprietary, intravitreal (IVT) platform, Adverum is developing durable, single-administration therapies, designed to be delivered in physicians’ offices, to eliminate the need for frequent ocular injections to treat these diseases. Adverum is evaluating its … Type: | 0 | 0 | 0 | 141 |
 | ZEDIRA GmbH Targeting Transglutaminase for Research & Medicine! ZED1227 First Tissue Transglutaminase Inhibitor in Clinical Trials! Zedira is specialist and global brand for transglutaminase. More than 200 specialty reagents for transglutaminase-related R&D. Researchers from academia and industry (including 12 of the top 15 big pharma companies) benefit from Zedira’s cutting edge products – and in an increasing manner – from customised services. Solutions for site specific labeling of proteins using transglutaminases form Zedira’s latest product field. Simply - "The Transglutaminase Company" and From bench to bedside Type: | 0 | 0 | 0 | 10 |
 | OakLabs Scientific Reach New Heights With Your Biomarkers At OakLabs Scientific, we believe that each of us can live longer healthy. In a society where individual healthcare is increasingly challenging, we are pioneering ways to detect and avert disease before it occurs. Using our unique Artificial Intelligence algorithms and high-molecular-weight data, we are exploring individual health status in unprecedented depth. gene expression analysis, biotechnology, research, biomarkers, biomarker signatures, and companion diagnostics Type: | 0 | 0 | 0 | 10 |
 | ChromoTek new tools for better research #newtoolsforbetterresearch Part of Proteintech Group. ChromoTek pioneered the development and commercialization of alpaca Nanobodies. As a market and product leader for high quality and reliable Nanobody-based reagents, we assist scientists’ research world-wide. In addition, ChromoTek is a trusted service provider of custom-made Nanobodies for the pharmaceutical industry. Founded in 2008 ChromoTek has offices in Martinsried, Germany, and Hauppauge, NY. In contrast to traditional antibodies Nanobodies consist of only one single polypeptide chain; they are 15 kDa and the smallest antibodies known. ChromoTek GmbH, Affinity purification, Immunoprecipitation, Co-IP, Mass spectrometry, Ligand capture, Protein-protein interaction, GFP-Trap, Fluorescent … Type: | 0 | 0 | 0 | 15 |
 | Easy Medical Device Consulting Agency. Help you place your Compliant Medical Device on the market Easy Medical Device is a company that will support you to place your Medical Device on the market. With its network, the company is capable of finding you the right support you need to execute your tasks. If you have a project to develop or a problem to solve in terms of Quality and Regulatory Affairs, Easy Medical Device is your solution. We help companies that are bringing new devices on the market or companies that just need an upgrade of their system. We can also find you … Type: | 0 | 0 | 0 | 11 |
 | VectorBuilder VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to … Type: | 2 | 1 | 1 | 75 |
 | DBS System Making blood samples travel - not people. DBS System is a medtech company located in the Swiss Health Valley providing advanced technology to collect and prepare blood samples in a less invasive, easier, cheaper, safer manner with precision and industry standard processes. We produce devices with patent pending microfluidic technology capable of plasma/serum extraction and volume control in a standardized and reliable format, dramatically increasing the potential of DBS samples in bioanalysis. The innovative HemaXis platform was developed to combine the power of labs to test and monitor health with people’s desire to stay well. HemaXis will help democratize blood … Type: | 1 | 0 | 1 | 6 |
 | Kiyatec Inc. Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and … Type: | 1 | 0 | 1 | 25 |
 | Q-linea At Q-linea, we design, develop, and deliver innovative technology to aid physicians and technicians to improve patient outcomes and save lives. We aim to vastly reduce the time to optimal therapy. Q-linea provides infectious disease diagnostics to create sustainable healthcare, now and in the future. For patients, physicians, and society. The company’s leading product, ASTar®, is a fully automated instrument for antimicrobial susceptibility testing, which produces a sensitivity profile from a positive blood culture within approximately six hours. This is 24 to 40 hours faster than current diagnostics. This contributes to reducing the use of broad-spectrum antibiotics. ASTar is CE-IVD … Type: | 0 | 0 | 0 | 118 |
 | Seres Therapeutics Leading the Microbiome revolution Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in … Type: | 3 | 1 | 1 | 313 |
 | MRM Health Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition … Type: | 1 | 1 | 0 | 48 |
 |  MV BioTherapeutics SA A Microbiota biotherapeutics and Vaccines company A Swiss Microbiota biotherapeutics and Vaccines company, a spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona. The patent protected Apy platform is a unique mechanism to generate protective immune response against enteric infections and to shape the intestinal microbiota in medical conditions with two applications: 1. ApyraVax® with the lead indication of Clostridium difficile infection 2. ApyraMed® with lead indications as enhancer in cancer immunotherapy and modulator of antibiotic-induced disbyosis. Research experiments and preclinical trials are performed in the research lab hosted at IRB. The company is looking for seed funding … Type: | 1 | 1 | 0 | 1 |
 | OPPILOTECH LTD Navigating Biology, Discovering Drugs Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the models to simulate biological processes in order to identify viable drug targets and discover new biology. The company is building a pipeline of first-in-class drug discovery programmes based on the identified targets. Type: | 1 | 1 | 0 | 10 |
 | PEPperPRINT GmbH The leading provider of high-density peptide microarrays for antibody validation, epitope mapping & antigen discovery. PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by … Type: | 0 | 0 | 0 | 23 |
 | GQ Bio Therapeutics High-Capacity Gene Therapy Vector Platform to Address Prevalent Diseases GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. biotechnology, gene therapy, osteoarthritis, drug development, human … Type: | 0 | 0 | 0 | 15 |
 | Memo Therapeutics AG Memo Therapeutics AG is an innovator in the field of antibody discovery and immune repertoire analysis. Its DROPZYLLATM platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’s immune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. Combined with our microfluidic high throughput single cell-based functional screening system this leads to entirely new possibilities in immune repertoire analysis and antibody discovery. The business strategy of Memo Therapeutics is the discovery of … Type: | 1 | 0 | 1 | 28 |
 | VarmX VarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis. VarmX (www.varmx.com) is a young Leiden based biotech company that is focusing on the development of therapies in the field of hemostasis and thrombosis. Originally a spin-off from the Leiden University Medical Center (LUMC), our mission is to develop and manufacture therapeutic proteins to restore hemostasis. Our lead compound, VMX-C001, is intended to safely and effectively restore hemostasis in case of bleeding or emergency surgery in patients taking so-called oral factor Xa inhibitors. The VarmX program has gained significant interest in … Type: | 0 | 0 | 0 | 26 |
 | Minervax ApS Developing a maternal vaccine for Group B Streptococcus MinervaX is pursuing the development of a maternal vaccine for the prevention of adverse pregnancy outcomes and life-threating infections caused by Group B streptococcus (GBS). The vaccine is based on adjuvanted proteins antigens covering close to 100% of clinical GBS isolates. Group B Streptococcal (GBS) is the leading cause of life-threatening infections in newborns. Colonization of pregnant women with GBS may lead to adverse pregnancy outcomes such as late abortions, stillbirths, and preterm delivery. Colonization may also lead to life-threatening infections in newborns for the first 3 months of life, causing pneumonia, … Type: | 0 | 0 | 0 | 49 |
 | Acousia Therapeutics GmbH Enhance & Preserve Natural Hearing ! Acousia is a pioneer of novel medicines. Founded in 2012, the company’s experienced and entrepreneurial management team is committed to combating hearing loss. Thanks to its exclusive collaboration agreement with the renowned Translational Hearing Research Group of Tuebingen University Clinic and an ecosystem of experts and CROs, Acousia has made significant strides with its advanced small molecule drug candidates. Hearing Loss Treatment and Hearing Loss Drug Development Type: | 0 | 0 | 0 | 5 |
 | Manina Medtech Boosting In Vitro Fertilisation Success Infertility is a global health problem, with a rising incidence, affecting one in every six couples and 190 million people worldwide. In Vitro Fertilisation (IVF), one of the most known infertility treatments, has gained awareness and clients. However, of the nearly a million IVF cycles done in Europe annually, only 40% result in pregnancy. Low IVF success makes the process long, expensive, and emotionally devastating. Manina Medtech is a young startup with a B2B business model and the vision that every woman who goes through IVF requires a single IVF cycle to get pregnant. We … Type: | 1 | 0 | 0 | 5 |
 | Qorium Real Leather, Reinvented Leather is loved. Leather is luxury. Leather is everywhere. Unfortunately, making leather is also polluting, challenging and controversial. Qorium creates beautiful, premium, and authentic leather without compromise. Cutting-edge science empowers us to dramatically reduce the vast impacts of today’s leather industry without quality reductions. By removing the cow from leather production, Qorium’s material has minimal climate impacts, low water and chemical usage, no land use, and no animal impacts. Simply put, Qorium reinvents leather. Better product. Better planet. Biotechnology, Cell cultured leather, Leather, Cell grown Leather, Sustainable Leather, and Animal free Leather Type: | 1 | 0 | 1 | 16 |
 | MolDrug Chemoinformatics and modeling solutions to optimize your drug candidates. MolDrug is a company group specialized in the design and optimization of molecules through Machine Learning-powered chemoinformatics and structural bioinformatics. Our models allow for the prediction of molecular properties (QSAR) and detailed interaction analyses (molecular modelling). We work with all types of compounds, including small molecules, peptides, nanomaterials, mixtures... Our tools allow for the prediction and assessment of physicochemical, biological, pharmacological, and/or (eco)toxicological properties of substances with an array of advantages: - faster results - saving money and resources - reduce animal testing (3 Rs) - regulatory validity (REACH, CLP, ICH, … Type: | 0 | 0 | 0 | 1 |
 | Relation Discovering the relationships at the heart of biology to cure disease. We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select … Type: | 3 | 0 | 2 | 50 |
 | Lawford Davies & Co Life Sciences Advisors in the UK, North America, and Germany We are a niche life sciences advisory firm, and a full service law firm, with exceptional expertise in human tissue- and cell-based research, clinical care, and assisted reproduction. We advise established biotechnology companies as well as start-ups, fertility clinics, and biobanks. medical ethics, data protection, medical law, autonomy, biotechnology, clinical trials, consent, GDPR, Law, and Life sciences law Type: | 0 | 0 | 0 | 5 |
 | siTOOLs Biotech GmbH High Specificity Tools for RNAi, rRNA depletion & RNA Interactome Studies. Services: Making Sense of RNAi Screening Data We drive RNA research with tailored molecular tools. We are from Munich and provide researchers with highly complex & advanced genetic tools. Our core expertise is RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq. Distinguished by their exceptional targeting specificity and efficiency, our gene function analysis tools include - siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion. Our technology combines high complexity oligo pooling (“Pack Hunter” approach), proprietary design … Type: | 0 | 0 | 0 | 10 |
 | CYTENA We make the development of modern therapies faster, safer, and more affordable. Join us to create the future of health! We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other … Type: | 0 | 0 | 0 | 76 |
 | Circuit Clinical An IRO committed to better access to clinical research, the development of new medicines, and health equity. Circuit Clinical, one of the fastest-growing research networks in the USA, is dedicated to empowering patients to choose clinical research as a care option through improved access to clinical trials. Committed to transforming the experience of finding, choosing, and participating in clinical research for physicians and their patients, Circuit provides clinical research services through traditional, hybrid, and decentralized community-based site models and their MD Prescreen service that optimizes patient referrals. Learn more at circuitclinical.com Clinical Research Enrollment Solutions, Patient Recruiting Services, Clinical Site … Type: | 8 | 1 | 4 | 95 |
 | Menten AI Building the world's most advanced generative AI platform for peptide therapeutics design. Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We are developing the world's most advanced generative AI platform for peptide therapeutics. Type: | 6 | 1 | 4 | 15 |
 | HP Health Solutions Germany GmbH For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology Type: | 0 | 0 | 0 | 26 |
 | POXEL Poxel is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders. Poxel has clinical and earlier-stage programs from its adenosine monophosphate-activated protein kinase (AMPK) activator and deuterated TZD platforms targeting chronic and rare metabolic diseases. For the treatment of NASH, PXL065 (deuterium-stabilized R-pioglitazone) is in a streamlined Phase 2 trial (DESTINY1). PXL770, a first-in-class direct AMPK activator, has successfully completed a Phase 2a proof-of-concept trial for the treatment of NASH, which met its objectives. For the rare inherited metabolic disorder, adrenoleukodystrophy (ALD), the company intends to initiate … Type: | 2 | 2 | 0 | 27 |
 | SIGNIA THERAPEUTICS Breakthrough Solution for Respiratory Infections SIGNIA THERAPEUTICS is a research company based out of Bâtiment Adénine, 60 Avenue Rockefeller, 69008 Lyon, France Type: | 0 | 0 | 0 | 7 |
 | Drepacare [Automatic translation follows] Drepacare is the first mobile application intended for #sickle cell patients. Sickle cell anemia is the most widespread genetic disease in the world, 50 million people are affected, including 12,000 in France. Created in 2016 by three entrepreneurs/students in a Master's degree in nutrition and public health in parallel with their careers as pharmacists, nurses and engineers in biotechnology, it aims to make the daily lives of patients easier with functionalities that help manage treatments, diet, frequency of attacks, hospitalizations. The idea starting from the observation of a great lack of communication and information on sickle cell … Type: | 8 | 2 | 4 | 5 |
 | ErgoSanté ERGONOMICS FOR ALL ErgoSanté is a company specialized in the design, manufacturing, and distribution of customized ergonomic solutions aimed at maintaining employment for workers with disabilities and preventing musculoskeletal disorders (MSDs) risks. ErgoSanté distributes its products both nationally and worldwide. Our approach is unique: once your needs have been identified by healthcare professionals (such as occupational physicians, ergonomists, or employment support advisors), we lend you the recommended equipment for free so that you can judge the effectiveness of the proposed solution for yourself. We cater to both seated employees (with ergonomic chairs, height-adjustable desks, and accessories) and standing employees (with … Type: | 48 | 3 | 43 | 150 |
 | PrediSurge Precision Medicine Platform for Cardiovascular Interventions PrediSurge develops a precision medicine platform to assist physicians in better planning their endovascular interventions. Based on pre-operative imaging, our technology enables creation of patient-specific digital twins: numerical models simulating arteries and valves biomechanical behavior. In a clinical context, these digital models can be used to numerically investigate different device implantation approaches and to determine the best strategy for a specific patient. In an industrial context, use of digital twins boosts innovative product development by early de-risking of avant-garde technologies, compressing design iteration period and early prediction of in-vivo performances. It’s a cost-effective solution … Type: | 16 | 10 | 9 | 30 |
 | Continuum Plus Santé [Automatic translation follows] Reinventing the monitoring of patients on cancer drugs #AKOadom, Continuum+ Connect Remote Monitoring Platform Closer to patients. cancer, health, digital, E-health, Home support, and remote monitoring Type: | 32 | 3 | 28 | 17 |
 | Aenitis Technologies Acoustic Cell Processing Solution Aenitis develops and promotes devices for continuous, contactless and pressureless cells handling, using acoustic forces. Aenitis focuses on cell and gene therapy players' challenges by developing innovative cost-effective bioprocessing systems for cell sorting, cell washing, cell confinement and cell isolation. Sorting, acoustophoresis, medical devices, cells, and Bioproduction Type: | 19 | 3 | 17 | 15 |
 | BioAxial, part of Telight Explore the Unseen BioAxial is now part of Telight. Please follow our news at Telight LinkedIn page https://linkedin.com/company/telight TELIGHT specializes in a field of instruments employing light optics, in particular, providing innovative types and solutions for light microscopy. Super Resolution Microscopy, Fluorescence Microscopy, Conical Diffraction Optical Components, Nanoscopy, Living Cell Imaging, Low phototoxicity, Standard Workflow, Multicolor Imaging, and Intuitive Type: | 1 | 1 | 0 | 9 |
 | InBrain Pharma InBrain Pharma, a CNS disorders focused biotech, founded in 2018, exploiting through an exclusive worldwide patent license signed with the Northern France TTO, a groundbreaking therapeutic approach of advanced Parkinson’s Disease based on the research work of Pr David DEVOS and Pr Caroline MOREAU developed within their academic research Team from the Université́ de Lille, Lille Neuroscience & cognition UMR-S 1172 INSERM and the Lille University Hospital. To date, the company has raised €4.4 million in dilutive and non-dilutive financing, these funds having enabled to carry out a first phase I/IIb DIVE-I clinical trial on 12 patients, for which results … Type: | 9 | 3 | 6 | 6 |
 | BioC3 Synthetic Biology BioC3 is a French biotech startup that has created an innovative biocatalysis platform. This brings standardized and highly efficient reaction cascades thanks to stabilized enzymes. The reactions take place in water at ambient temperature and atmospheric pressure, using carbon sources that are renewable. No polluting by-product is generated. Type: | 0 | 0 | 0 | 5 |
 | DIAG2TEC Preclinical CRO in Hematological Cancers Diag2Tec is an expert preclinical CRO devoted to hematological cancers, especially Multiple Myeloma (MM). We focused on in vitro Drug Testing in Human Hematological Cancer derived Cell Lines and Primary Cells from patients with various Hematologic Malignancies (Multiple Myeloma, Diffuse Large B Cells Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Mantle cell Lymphoma, Chronic Lymphoid Leukemia...). With our 2 platforms : Drug Testing Services and ChimioFx, our mission is to provide efficient treatment solutions for patients suffering from Hematological Malignancies with Precision Medicine approaches. We support biotech and phamaceutical companies to focus their drug development on … Type: | 1 | 1 | 0 | 9 |
 | NeoVirTech Virus and viral vector imaging in living cells applied to antiviral discovery and disinfection processes NeoVirTech (NVT) is one of the leading virus imaging and antiviral discovery company in Europe. The company has been highlighted in the Top10 drug discovery companies, Europe, 2019 by the PharmaTechOutlook Magazine. NVT has developed a breakthrough technology to directly visualize and quantify in real time virus/viral vector infection and replication in living cells, from high resolution to high content imaging. At NeoVirTech, we believe everyone can have access to state-of-the-art virology techniques. We are focusing our activities on antiviral discovery, study of oncolytic and … Type: | 7 | 1 | 6 | 6 |
 | ORTHOPUS Handitech solutions for everyone ORTHOPUS is a high-impact start-up that designs innovative and accessible robotic assistants for people with motor disabilities. Founded by David Gouaillier, co-creator of the NAO robot, ORTHOPUS is at the crossroads of technology and solidarity. The company has been awarded the "Entreprise solidaire d'utilité sociale" label, and its aim is to democratise access to assistive technologies. The team of robotics engineers is developing a range of exoskeletons and robotic arms dedicated to arm mobility. Open source hardware, humanitaire, fabrication numérique, prosthetics, and frugal innovation Type: | 17 | 8 | 11 | 19 |
 | ODONTELLA [Automatic translation follows] The company has filed patents relating to the use of Odontella, the world's first marine microalgae authorized for human consumption. These patents concern the formulation, based on the marine microalgae Odontella, of a wide range of new agri-food products, healthy for the whole family. (Drinks, ready meals, etc.) The company is working on a new value chain, based on Odontella, by developing the first marine vegetable salmon that can directly replace the consumption of farmed salmon, in terms of taste, appearance , texture, nutritional quality but also price. This patented product developed in partnership with specialized laboratories … Type: | 1 | 1 | 0 | 2 |
 | HYPREVENTION Strutplasty pioneer, address fragile bone. Founded in 2010 by Cécile Vienney (CEO) and 3 orthopedic surgeons, Hyprevention is a French start-up located in France that develops, manufactures and markets implantable medical devices to reinforce weaken bone by osteoporosis or cancer thanks to the STRUTPLASTY® Technology. In 2021, Hyprevention INC was established in New-York - USA to promote V-STRUT© Vertebral Implant FDA cleared. www.hyprevention.com www.hypreventionusa.com V-STRUT© Vertebral Implant is indicated to treat vertebral fractures. The device is made of PEEK polymer, close to normal bone, and presents a pedicle anchorage to reinforce the full vertebrae. It is a unique solution on … Type: | 0 | 0 | 0 | 10 |
 | Rondol Group We created Rondol Industrie in 2012 with the goal of adapting Hot Melt Extrusion (HME) technology to the micro scale and to pharma standards and contributing therefore to better and cheaper healthcare. We are now HQ'd in Nancy, France. Rondol is a privately owned Deeptech company which patented the All-in-One Vertical twin screw extruder, representing a significant innovation in pharmaceutical manufacturing due to its capacity to increase the efficiency of drug formulation and delivery, and allowing for more effective therapeutic solutions. What sets this technology apart is its ability to handle complex formulations, enhance drug solubility, and improve bioavailability. These … Type: | 3 | 2 | 1 | 10 |
 | LABORATOIRES AXAMED SA [Automatic translation follows] HealthCare Innovation Partner Based in Paris, AXAMED® Laboratories have a strong capacity for innovation, specializing in the design, development and marketing of innovative health products in the vast field of family health, electronic self-diagnosis for medical use. , prevention and treatment of pain, family hygiene, well-being as well as innovative food supplements sold under the NovaBoost® brand. The innovative medical products and devices designed by AXAMED® Laboratories integrate technology and design and are focused on needs and uses. AXAMED® Laboratories products provide comfort of use and well-being for patients/users. health, medical devices, pain prevention and treatment, pharmaceutical, … Type: | 0 | 0 | 0 | 17 |
 | SOS ADDICTIONS [Automatic translation follows] To speak differently, to act differently. #addictions #opioids #cannabis #cocaine #tobacco #vape #RdR #alcohol #drugs #medication #ecig #screens #sex Type: | 7 | 1 | 1 | 8 |
 | Enterome Delivering the promise of immunotherapy We are a clinical stage biopharmaceutical company developing developing breakthrough immunomodulatory drugs for the treatment of cancer and inflammatory diseases. We have developed two highly promising pipelines of clinical and pre-clinical candidates with a focus on cancer and auto-immune diseases: - OncoMimicsTM: highly effective, off-the-shelf therapeutic vaccines against cancers (EO2401, EO2463). EO2401 is in Phase 1/2 clinical trials in patients with glioblastoma and adrenal tumors. EO2463 is in a Phase 1/2 clinical trial for indolent non-Hodgkin B-cell lymphomas. - EndoMimicsTM: a pipeline of next generation bioactives acting like human hormones or cytokines for the treatment … Tags: FrenchTech2030 Type: | 10 | 4 | 5 | 82 |
 | SeaBeLife Biotech Solutions to deprogram cell death : A breakthrough innovation to treat and prevent severe pathologies We develop small molecules that inhibit regulated necrosis using an original mechanism of action. Regulated necrosis is one of the recently identified pathophysiological factors in many diseases with severe outcomes. The technical, therapeutic and economic potential is major. Our activity focuses on the development of drugs inhibiting regulated necrosis, from the selection of the molecule to the proof of efficacy in the patient. We focus on acute and orphan diseases because preclinical and clinical development is facilitated, allowing proof of concept (POC) to be provided … Type: | 14 | 4 | 12 | 15 |
 | Perha Pharmaceuticals From Sea to Pharmacy Perha Pharmaceuticals is a biotech company identifying, optimizing and characterizing innovative, low molecular weight kinase inhibitors and developing them up to proof-of-concept in man. Perha Pharma focuses its research on two main diseases: cognitive disorders associated with Down syndrome (DS) and Alzheimer’s disease (AD), and hearing loss (HL) induced by ototoxic products. The first proof-of-concept in man should be achieved in both pathologies through niche indications: cognitive deficits in DS and hearing loss induced by cis-platin or aminoglycoside antibiotics. Perha Pharma was co-founded in April 2019 by Dr Laurent MEIJER, Chairman & CSO, former distinguished Director … Type: | 5 | 5 | 0 | 12 |
 | EryPharm EryPharm is a biotech start-up company dedicated to the development and the operation of a large-scale process for the production of Red Blood Cells from stem cells. The technology has been developed by Dr. Luc Douay and his team at the Paris Sorbonne university. You can contact EryPharm through our website: http://erypharm.com/contact.html Or you can contact Loïc Tron directly: www.linkedin.com/in/loictron Type: | 9 | 1 | 8 | 3 |
 | Japet Medical Medical technology for health at work. Japet Medical is a exoskeleton manufacturer and integrator. This European startup combines medical technologies, textile expertise and modern robotics to create devices that relieve everyday aches and pains. Its Japet.W+ exoskeleton is the only motorized exoskeleton that protects employees' backs in all their movements. Every day, Japet Medical's teams help companies successfully integrate exoskeletons to combat musculoskeletal disorders. Find us on : https://www.japet.eu/ Robotics, Healthcare, Exoskeleton, Rehabilitation, health at work, Wearable Medicine, exosquelette, TMS, prévention, robotique, SST, QVCT, and RQTH Type: | 24 | 10 | 12 | 36 |
 | REGEnLIFE Neurotech & photomedicine REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia. MedTech, NeuroTech, Neurophonic, Photonics, … Type: | 13 | 2 | 11 | 12 |
 | MT-act FROM DISCOVERY TO THERAPEUTICS MT-act is a CNRS spin-off. #techtransfer We develop class compounds to treat human pathologies that share a common molecular defect; dysfunction of the skeleton of the cells called microtubules - abbreviated MT. Stiffening of the skeleton of our cells is a central disease driver. That is why we act on them. We developed a technology platform to charter an entirely neglected pharmaceutical space. MT-act prioritizes indications based on scientific evidence, proven unmet medical needs and where the roadmap to patients is feasible and desired. Drug development, Microtubules, Tubulin code, Preclinical, Drug screening, first-in-class, and drug discovery Type: | 2 | 1 | 1 | 7 |
SMB